Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000950170-24-110485)

Filing Details

Accession Number:: 0000950170-24-110485
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-09-30 19:12:50
Reporting Period:: 2024-09-27

Accepted Time:: 2024-09-30 19:12:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1590750	Viridian Therapeutics Inc.	VRDN	Services-Medical Laboratories (8071)	471187261

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1741382	W. Thomas Beetham	C/O Viridian Therapeutics, Inc. 221 Crescent Street, Suite 103A Waltham MA 02453	Chief Operating Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-09-27	5,000	$23.41	6,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Includes 1,000 shares acquired under Viridian Therapeutics, Inc.'s 2016 Employee Stock Purchase Plan (the "ESPP") on September 19, 2024 in transactions that were exempt under Rule 16b-3(c).